𝔖 Bobbio Scriptorium
✦   LIBER   ✦

191 Phase II trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer

✍ Scribed by J.J. Knox; D. Hedley; A. Oza; L. Siu; R. Feld; E. Chen; M. Nematollahi; G. Pond; M. Moore

Book ID
118620366
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
313 KB
Volume
1
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Expanded phase II trial of gemcitabine a
Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer
✍ Rachel P. Riechelmann; Carol A. Townsley; Sheray N. Chin; Gregory R. Pond; Jenni πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 85 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. A phase 2 trial of gemcitabine and capecitabine (GemCap) in patients with advanced biliary cancer led to an objective response in approximately 30% of patients and a median survival of 14 months. In the current study, the authors report further efficacy data of a larger